Nasdaq confirms eargo's minimum bid price deficiency is cured

San jose, calif., feb. 06, 2023 (globe newswire) -- eargo, inc. (nasdaq: ear) (the “company” or “eargo”), a medical device company on a mission to improve the quality of life of people with hearing loss, announced today that it received a letter from the nasdaq stock market llc (“nasdaq”) dated february 1, 2023 informing eargo that the company's minimum bid price deficiency has been cured.
EAR Ratings Summary
EAR Quant Ranking